CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $36.73, but opened at $39.20. CochLear shares last traded at $39.20, with a volume of 455 shares trading hands.
Analyst Ratings Changes
Several brokerages recently issued reports on CHEOY. Zacks Research lowered shares of CochLear from a “hold” rating to a “strong sell” rating in a research note on Monday. UBS Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold”.
Check Out Our Latest Research Report on CochLear
CochLear Stock Performance
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
- Five stocks we like better than CochLear
- Draining the Tank: Big Oil Runs on Fumes
- Microsoft’s Xbox Problem Is Bigger Than a Console War
- Dave & Buster’s Q1 Miss Raises the Stakes for Its Turnaround Plan
- Flying Under the Radar: Lockheed Martin’s $2.8B Stealth Setup
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
